VLDL-R / VLDL receptor antibody
Principal name
VLDL-R / VLDL receptor antibody
Alternative names for VLDL-R / VLDL receptor antibody
VLDLR, VTG receptor, VTGR, Vitellogenin receptor
Ncbi ID
NP_001018066.1, 9606, NP_001154892.1, NM_001161420, NM_013703, NM_003383
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Flow Cytometry (F), Immunohistochemistry (IHC), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P)
Background of VLDL-R / VLDL receptor antibody
- Kit Component:
- - KN318900G1, Vldlr gRNA vector 1 in pCas-Guide vector
- KN318900G2, Vldlr gRNA vector 2 in pCas-Guide vector
- KN318900D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Ruiz, J., et al. (2005), J. Lipid Res., 46: 1721- 1731
Western Blot: VLDL Receptor Antibody (6A6) - Western blot analysis of VLDL Receptor expression in mouse kidney using anti-VLDL.
Immunocytochemistry: VLDL Receptor Antibody (6A6) - VLDL Receptor antibody was tested in HeLa cells with FITC (green). Nuclei and actin were counterstained with Dapi (blue) and Phalloidin (red).
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using (VLDLR Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using (VLDLR Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA309928 | VLDL-R / VLDL receptor antibody |
||||||
| Mouse Monoclonal VLDL Receptor Antibody (6A6) | |||||||
 |
Mouse | IgG1 | 6A6 | Purified | Bov, Hu, Ms, Rt | ICC/IF, WB |
0.1 ml /
€395.00
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA351915 | VLDL-R / VLDL receptor antibody |
||||||
| Rabbit Polyclonal Anti-VLDLR Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| +1 additional image |
|||||||
| AM00969PU-N | VLDL-R / VLDL receptor antibody |
||||||
 |
Mouse | IgG1 | B047M | Purified | Hu | E, WB |
0.2 mg /
€430.00
|
| OriGene Technologies GmbH | |||||||
| AM00970PU-N | VLDL-R / VLDL receptor antibody |
||||||
|
Mouse | IgG1 | B046M | Purified | Hu | E |
0.2 mg /
€390.00
|
| OriGene Technologies GmbH | |||||||
| AM00971PU-N | VLDL-R / VLDL receptor antibody |
||||||
|
Mouse | IgG1 | B045M | Purified | Hu | E, WB |
0.2 mg /
€520.00
|
| OriGene Technologies GmbH | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN211796 | VLDLR - human gene knockout kit via CRISPR |
||
|
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN211796BN | VLDLR - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN211796LP | VLDLR - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN211796RB | VLDLR - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC211796L2V | Lenti ORF particles, VLDLR (mGFP-tagged) - Human very low density lipoprotein receptor (VLDLR), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
| RC211796L1V | Lenti ORF particles, VLDLR (Myc-DDK tagged) - Human very low density lipoprotein receptor (VLDLR), transcript variant 1 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,000.00
|
|
| OriGene Technologies, Inc. | ||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR226657L2V | Lenti ORF particles, Vldlr (GFP-tagged) - Mouse very low density lipoprotein receptor (Vldlr), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,710.00
|
|
| OriGene Technologies, Inc. | ||
| MR210931L2V | Lenti ORF particles, Vldlr (GFP-tagged) - Mouse very low density lipoprotein receptor (Vldlr), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||
| MR226657L1V | Lenti ORF particles, Vldlr (Myc-DDK-tagged) - Mouse very low density lipoprotein receptor (Vldlr), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,540.00
|
|
| OriGene Technologies, Inc. | ||
| MR210931L1V | Lenti ORF particles, Vldlr (Myc-DDK-tagged) - Mouse very low density lipoprotein receptor (Vldlr), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,330.00
|
|
| OriGene Technologies, Inc. | ||
